Covid-19 Vaccinations: 12 to 15-year-olds

Graham Brady Excerpts
Monday 13th September 2021

(2 years, 7 months ago)

Commons Chamber
Read Full debate Read Hansard Text Read Debate Ministerial Extracts
Nadhim Zahawi Portrait Nadhim Zahawi
- Hansard - - - Excerpts

Our regulator has only regulated the vaccines for 12 to 15-year-olds. I reiterate the point that the school-age vaccination programme and the infra-structure we have is very well versed in delivering vaccines and gaining consent. Of course, the NHS in England—the same is happening in Scotland, Wales and Northern Ireland—has been thinking through exactly how the communication, the comms and the leaflets, will be provided to parents so that they have the information necessary to be able to make the decision for their child to be vaccinated.

Graham Brady Portrait Sir Graham Brady (Altrincham and Sale West) (Con)
- Hansard - -

The Minister praised JCVI, quite rightly, but it is clear from the advice it gave recently that what was weighing most heavily on its mind was the lack of long-term evidence about the possible adverse reactions due to myocarditis following vaccination. As it said just 10 days ago:

“substantial uncertainty remains regarding the health risks associated with these adverse events.”

What has happened in the last 10 days to remove that uncertainty?

Nadhim Zahawi Portrait Nadhim Zahawi
- Hansard - - - Excerpts

The important thing to remember is that the JCVI’s advice was very much predicated on what it was clinically qualified to look at. It was its recommendation to the chief medical officers to then take a further look. My hon. Friend will recall that JCVI’s advice was that, on balance, it is beneficial for children to have the vaccine rather than not have the vaccine, but not enough to recommend a universal programme, hence its advice to CMOs to go further on that. The work the CMOs have done in recommending a single dose is very much predicated on the data they have seen. JCVI, by the way, were in the room during the deliberations from America and elsewhere on the myocarditis on the second dose.